ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1196

Association of High Albumin-Corrected Anion Gap with Mortality in Patients with CKD: Retrospective Analysis of the MIMIC-IV Database

Session Information

Category: CKD (Non-Dialysis)

  • 2302 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Authors

  • Li, Piao, Changsha Central Hospital, Changsha, Hunan, China
  • Xie, Rou, Changsha Central Hospital, Changsha, Hunan, China
  • Wen, Rui, Changsha Central Hospital, Changsha, Hunan, China
  • Qin, Jiao, Changsha Central Hospital, Changsha, Hunan, China
Background

In patients with advanced chronic kidney disease (CKD), disturbances in acid-base balance are common. The anion gap (AG) is a metric used to assess acid-base status, but various factors can influence it. The albumin-corrected anion gap (ACAG) adjusts AG for the effect of albumin levels. This study investigated the relationship between ACAG and all-cause mortality (ACM) in CKD patients treated in the intensive care unit (ICU).

Methods

We extracted CKD patients from the MIMIC-IV database. Patients were then stratified into groups (quartiles) based on their ACAG levels. Mortality was assessed at various time points: in-hospital, 30 days, 90 days, and 365 days after ICU admission. Cox proportional hazards regression and restricted cubic splines (RCS) were used to analyze the relationship between ACAG and ACM. Additionally, Kaplan-Meier curves were estimated to depict survival probability.

Results

The study included 1,370 patients, with 62.5% being male. Mortality rates were concerning, with 35.5% dying in the hospital, 44.7% within 30 days, 59.8% within 90 days, and 78.9% within 365 days of ICU admission. The adjusted hazard ratios (HRs) were 2.95, 2.67, 2.28, and 1.96 at each respective time point, with all p values less than 0.001. RCS analysis revealed a linear increase in mortality risk with rising ACAG levels, particularly when exceeding 19 mmol/L. Increased ACAG levels were associated with ACM across all subgroups.

Conclusion

Our findings demonstrate a significant correlation between elevated ACAG and ACM in CKD patients admitted to the ICU.

Digital Object Identifier (DOI)